Insiders · Profile

Xu Cong Claire

EVP, Clinical Development at NovaBridge Biosciences. Filing since 1 Jun 2026. CIK 0002114309

Company

Date

Role

Action

Amount

Of holding

31 Aug 2026

EVP, Clinical Development

Sold at will

3,282

$2.59K

1.1%

6 Jul 2026

SVP, Clinical Development

Sold at will

4,485

$3.99K

1.5%

1 Jun 2026

SVP, Clinical Development

Sold at will

3,494

$13.77K

1.2%

3 decisions on file.